Nicardipine Hydrochloride

盐酸尼卡地平

Report date: 2022/05/13 17:39:57
NME

Base Information

Drug NameNicardipine Hydrochloride
Drug Alias Name尼卡迪平Nicardipinum HydrochlorideNicardipino Hydrochloride尼龙卡地平硝苯苄胺啶 +[22] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsHypertensionAortic Aneurysm, ThoracicCoronary Artery Disease +[9] 
Global Approved IndicationsHypertensionAngina, StableAngina Pectoris
Approved Indications in ChinaHypertensionAngina Pectoris
Original Approved Country/TerritoryMainland China
Original Approved Date1988/01/01
Country/TerritoryCanadaUnited StatesTaiwan +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChiesi Farmaceutici SPA
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Disainuo Pharmaceutical Co LtdBit Pharma Gmbh
Inactive CompaniesUniversity Of MinnesotaChiesi Usa IncDuke University +[6] 
Active IndicationsHypertensionAngina PectorisSubarachnoid Hemorrhage
Inactive IndicationsAortic Aneurysm, ThoracicCoronary Artery DiseaseAngina, Stable +[6] 

Other Information

ATC CodeC08CA04
Related LinksWikipediaDrugBankKEGG